EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Current mechanistic insights into Withaferin A: a promising potential adjuvant anticancer agent from Withania somnifera

Muhammad Farrukh Nisar, Chunpeng Wan, Dietrich Büsselberg, Daniela Calina, Javad Sharifi-Rad

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025-04 · 398 (4) · 3573-3593

DOI: 10.1007/s00210-024-03662-y ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 30.11.2024. Verfasst von Muhammad Farrukh Nisar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Biochemistry, Cholistan University of Veterinary and Animal Sciences (CUVAS), Bahawalpur, 63100, Pakistan. Hauptthemen laut MEDLINE: Withania, Withanolides, Neoplasms, Antineoplastic Agents, Phytogenic. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 87 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer remains a global health challenge, with drug resistance and disease recurrence posing significant obstacles despite advances in immunotherapy and targeted treatments. This has driven interest in natural products as sources of novel anticancer agents. Withania somnifera (Ashwagandha), a well-regarded plant in Ayurvedic medicine, is noted for its various therapeutic properties, including anticancer effects. Among its bioactive compounds, Withaferin A (WFA), a steroidal lactone, has shown notable promise in reducing inflammation, angiogenesis, and tumor proliferation with minimal toxicity. This review examines the anticancer properties of WFA, with a focus on its mechanisms of action, therapeutic efficacy, and safety profile across various cancer types. A comprehensive literature review was conducted, compiling data from in vitro and in vivo studies that investigate WFA's impact on cancer hallmarks, including apoptosis induction, angiogenesis reduction, and metastasis inhibition. Key molecular interactions with NFκB, STAT, HSP90, estrogen receptors, p53, and TGFβ pathways are highlighted. Findings indicate that WFA exhibits significant anticancer activity by modulating critical signaling pathways and inducing apoptosis with minimal adverse effects. In preclinical models, WFA demonstrated therapeutic potential across multiple cancers, such as breast, colon, prostate, ovarian, lung, and brain cancers. WFA represents a promising candidate for future cancer therapies, particularly as a natural adjuvant that could enhance treatment efficacy with low toxicity. Further clinical trials are needed to explore WFA's full potential and confirm its safety in human oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

WithaniaWithanolidesNeoplasmsAntineoplastic Agents, PhytogenicHumansAnimals

Stichwörter der Autor:innen

Anticancer mechanismsApoptosisAshwagandhaMetastasisWithaferin A

Substanzen

withaferin AWithanolidesAntineoplastic Agents, Phytogenic

Autor:innen und Institutionen

  • Department of Physiology and Biochemistry, Cholistan University of Veterinary and Animal Sciences (CUVAS), Bahawalpur, 63100, Pakistan.
  • Jiangxi Key Laboratory for Postharvest Technology and Nondestructive Testing of Fruits & Vegetables, College of Agronomy, Jiangxi Agricultural University, Nanchang, 330045, China.
  • Jiangxi Key Laboratory for Postharvest Technology and Nondestructive Testing of Fruits & Vegetables, College of Agronomy, Jiangxi Agricultural University, Nanchang, 330045, China. chunpengwan@jxau.edu.cn.
  • Weill Cornell Medicine-Qatar, Education City, Qatar Foundation, P.O. Box 24144, Doha, Qatar.
  • Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, 200349, Craiova, Romania. calinadaniela@gmail.com.
  • Universidad Espíritu Santo, Samborondón, Ecuador. javad.sharifirad@gmail.com.

Zitieren

APA

Nisar, M. F., Wan, C., Büsselberg, D., Calina, D., & Sharifi-Rad, J. (2025). Current mechanistic insights into Withaferin A: a promising potential adjuvant anticancer agent from Withania somnifera. Naunyn-Schmiedeberg's Archives of Pharmacology, 398(4), 3573-3593. https://doi.org/10.1007/s00210-024-03662-y

Vancouver

Nisar MF, Wan C, Büsselberg D, Calina D, Sharifi-Rad J. Current mechanistic insights into Withaferin A: a promising potential adjuvant anticancer agent from Withania somnifera. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025;398(4):3573-3593. doi:10.1007/s00210-024-03662-y

BibTeX
@article{Nisar2025,
  author = {Nisar, Muhammad Farrukh and Wan, Chunpeng and Büsselberg, Dietrich and Calina, Daniela and Sharifi-Rad, Javad},
  title = {Current mechanistic insights into Withaferin A: a promising potential adjuvant anticancer agent from Withania somnifera},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  volume = {398},
  number = {4},
  pages = {3573--3593},
  doi = {10.1007/s00210-024-03662-y}
}
Kostenlos starten →